Determinants of injecting insulin in elderly patients with type II diabetes mellitus. 1993

B H Wolffenbuttel, and C H Drossaert, and A P Visser

In patients with type II diabetes mellitus blood glucose control may gradually worsen despite diet and oral hypoglycaemic agents. We investigated which possible factors determine the decision for elderly type II diabetic patients to start with insulin therapy in this situation. According to Fishbein and Ajzen an attitude-behaviour model was constructed which included the determinants intention, attitude, subjective norm and self-efficacy. Fifty-three patients (age 68 +/- 9 years) participated in the study: 26 already used insulin for 7 months, 27 were tablet-treated but poorly-controlled (fasting blood glucose > 8.0 mmol/l and glycosylated haemoglobin > 8.0%). In both groups of patients, a high correlation (r = 0.81, P < 0.001) existed between the intention to and the actual start or continuation of insulin therapy. The main factor (70%) explaining the intention towards insulin treatment was the subjective norm: patients are guided by the opinion of important other persons, especially the treating internist, the family physician and the diabetes nurse. Tablet-treated patients reported a negative opinion of their physician towards their treatment with insulin. Intention to behaviour was also determined by self-efficacy, e.g. expectations about the skills concerning injecting insulin. Self-monitoring of blood glucose and knowledge about diabetes positively influenced self-efficacy, attitude towards and intention to use insulin. Education needs to enforce the subjective norm and improve the patient's self-efficacy. A stimulating attitude of the treating physician towards insulin therapy is essential.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007722 Health Knowledge, Attitudes, Practice Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL). Knowledge, Attitudes, Practice
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008960 Models, Psychological Theoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment. Model, Mental,Model, Psychological,Models, Mental,Models, Psychologic,Psychological Models,Mental Model,Mental Models,Model, Psychologic,Psychologic Model,Psychologic Models,Psychological Model
D010342 Patient Acceptance of Health Care Patients' willingness to receive health care. Acceptability of Health Care,Health Care Seeking Behavior,Acceptability of Healthcare,Acceptors of Health Care,Health Care Utilization,Nonacceptors of Health Care,Patient Acceptance of Healthcare,Care Acceptor, Health,Care Acceptors, Health,Care Nonacceptor, Health,Care Nonacceptors, Health,Health Care Acceptability,Health Care Acceptor,Health Care Acceptors,Health Care Nonacceptor,Health Care Nonacceptors,Healthcare Acceptabilities,Healthcare Acceptability,Healthcare Patient Acceptance,Healthcare Patient Acceptances,Utilization, Health Care
D003657 Decision Making The process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea. Credit Assignment,Assignment, Credit,Assignments, Credit,Credit Assignments
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B H Wolffenbuttel, and C H Drossaert, and A P Visser
January 1995, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
December 2011, Expert opinion on pharmacotherapy,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
March 2004, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
September 1999, Clinical physiology (Oxford, England),
B H Wolffenbuttel, and C H Drossaert, and A P Visser
November 1996, International journal of clinical pharmacology and therapeutics,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
March 2015, Diabetes technology & therapeutics,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
January 1990, Advances in second messenger and phosphoprotein research,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
July 2009, Iranian biomedical journal,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
September 2015, Journal of diabetes investigation,
B H Wolffenbuttel, and C H Drossaert, and A P Visser
March 1993, The Nursing clinics of North America,
Copied contents to your clipboard!